SOLICITATION NOTICE
A -- Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than a Coventional Residences Receiving such Patients
- Notice Date
- 4/2/2014
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Nuclear Regulatory Commission, Acquisition Management Division, Acquisition Management Division, 11555 Rockville Pike, Rockville, Maryland, 20852-2738, United States
- ZIP Code
- 20852-2738
- Solicitation Number
- NRC-HQ-60-14-R-0006
- Archive Date
- 5/3/2014
- Point of Contact
- Geoffrey H. Coleman, Phone: 301-287-0934
- E-Mail Address
-
geoffrey.coleman@nrc.gov
(geoffrey.coleman@nrc.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- The U.S. Nuclear Regulatory Commission (NRC) intends solicit proposals under solicitation number NRC-HQ-60-14-R-0006 for a procurement to provide the NRC with assistance in gathering statistical data on the destinations of released patients following treatment with Iodine-131. The solicitation will be competitive and set-aside for Total Small Businesses. The NAICS code is 541712 with a size standard of 500 employees. The contact type will be cost-plus-fixed-fee. Background: Radioactive iodine, mainly the isotope Iodine-131, is used in the diagnosis and treatment of several medical conditions, the primary ones in the present context being treatment of hyperthyroidism and thyroid cancer following The objective of this scope of work is to achieve the following: Although most patients return to their home after receiving diagnostic or therapeutic administrations of iodine-131, some patients released by the licensee may stay at another location (such as a hotel) for a few days. However, the extent of this practice is unclear. The same uncertainty exists regarding patients returning to nursing homes and other institutional settings. Therefore, one of the main objectives of this study is to obtain reliable statistical data that provides good estimates of the prevalence of these practices. The second objective is to determine, by measurements, the external and internal doses received by members of the general public at hotels, nursing homes, or other institutional settings that receive treated patients immediately after their release. The importance of these conditions arises from the fact that their treatment protocols generally call for administration of relatively large doses of Iodine-131, and such patients therefore pose the greatest potential for exposure of others. Patients are often released from the hospital or clinic following treatment if they meet the release conditions specified in the Nuclear Regulatory Commission's (NRC) Code of Federal Regulations (CFR) Title 10, Part 35.75, "Release of individuals containing unsealed byproduct material or implants containing byproduct material." The basic criterion underlying the release conditions is that "the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 mSv (0.5 rem)." To assist licensees in implementing the above release requirement, NRC published Regulatory Guide 8.39, "Release of patients administered radioactive materials." This guide provides formulas and tables that are considered acceptable to NRC in translating the basic 5 mSv requirement into operational quantities to be used in releasing patients. For example, an operational quantity used in releasing patients is the dose rate measured at a specified distance from the patient. The formulas and tables in the guide use very conservative assumptions in estimating the dose to an individual that results from exposure to the released patient, but the guide also permits licensees to base their calculations on patient-specific conditions, which are often much less conservative than the generic conditions. A review of technical publications suggests that the release condition of 5 mSv noted above is being met in practice. While there is analytical information indicating that our current requirements are appropriate, there does not appear to be much empirical (field measurement) data regarding the doses actually being received by members of the public that are exposed to these patients. Therefore, the Commission instructed the staff to obtain a limited amount of analytical and empirical data collected from field measurements with particular interest in ensuring that any data that is acquired from patients can be obtained in a manner that avoids factors that would skew the results and the information collected will be representative of behaviors of a majority of members of the public to the maximum extent possible. During a NRC staff literature review, it was ascertained that some patients do not return to their home after release from licensee supervision. For example, some elderly patients or those in poor health may stay at a nursing home or similar complete care facility before and after their treatment with iodine-131. There is little information available in the open literature on procedures used at these facilities to control exposure of other patients and staff to ionizing radiation or methods used to control the spread of contamination at the facility. Other alternative residences may include hotels and institutions like prisons. Therefore, the NRC wants to identify the alternative destinations released patients may reside and what internal and external exposures members of the public might receive in order to determine if the release criteria outlined in 10 CFR Part 35.75 is adequately protective of public health and safety. Objective: The objective of this scope of work is to achieve the following: Although most patients return to their home after receiving diagnostic or therapeutic administrations of iodine-131, some patients released by the licensee may stay at another location (such as a hotel) for a few days. However, the extent of this practice is unclear. The same uncertainty exists regarding patients returning to nursing homes and other institutional settings. Therefore, one of the main objectives of this procurement is to obtain reliable statistical data that provides good estimates of the prevalence of these practices. The second objective is to determine, by measurements, the external and internal doses received by members of the general public at hotels, nursing homes, or other institutional settings that receive treated patients immediately after their release. Brief Description of Scope: The scope of work is divided into specific task. It shall be noted that, because the statement of work may involve collection of data on human subjects and monitoring of persons exposed to radiation, the contractor shall comply with the Common Rule and obtain an approval from an Institutional Review Board in advance prior to performing this work according to 45 CFR 46, subpart A and obtain signed informed consent from the participants. Task 1: Task 1 consists of assessing where patients reside immediately following their release. The contractor shall gather data to determine where patients reside after being released from licensee care. Specifically, what is the prevalence of patients going to locations other than their home. Task 2: Task 2 consists of measuring doses to members of the general public. The contractor shall determine whether radiological exposure/contamination data can be collected based on the results of Task 1. Task 3: Task 3 consists of analyzing all of the data and providing the Final Report. The contractor shall present the results of Task 1 & Task 2 in the form of a NUREG/CR detailing the project. Task 4: Task 4 consists of providing technical support. The contractor shall provide technical support on an as needed basis. This support could involve assistance translating the project results into future NRC guidance documents. Period of Performance This procurement is expected to be awarded in fiscal year 2014 and the expected period of performance is 2 years. Additional Information The solicitation will be released on or about April 18, 2014 with closing date on or about May 19, 2014. Interested parties are responsible for monitoring the FedConnect website and the FedBizOpps website to assure that they have the most up-to-date information regarding this procurement. In addition, all interested parties should watch this synopsis for updated information (if any) to the release date and for release of the solicitation. Once released, the solicitation and all amendments will only be available through the FedBizOpps website at https://www.fbo.gov, and through FedConnect at https://www.fedconnect.net. All interested offerors must be registered in FedConnect in order to be able to submit a proposal. No phone calls please.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/NRC/OA/DCPM/NRC-HQ-60-14-R-0006/listing.html)
- Place of Performance
- Address: The work to be performed under this contract will be primarily performed in a facility provided by the contractor., United States
- Record
- SN03326791-W 20140404/140402234526-6c68707616608651df757ac712502cb3 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |